UPDATED Apr 22, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$400.96 | -3.3% | 45.6% | US$3.0t | US$471.24 | PE36.1x | E12.6% | 0.7% | Software | ||
GOOGL | US$156.28 | 1.2% | 50.5% | US$2.0t | US$166.83 | PE26.3x | E11.8% | n/a | Media | ||
AMZN | US$177.23 | -3.3% | 72.8% | US$1.8t | US$209.79 | PE60.6x | E21.6% | n/a | Retail | ||
META | US$481.73 | -3.6% | 132.1% | US$1.2t | US$541.20 | PE31.3x | E14.4% | 0.4% | Media | ||
LLY | US$731.33 | -2.1% | 90.0% | US$658.8b | US$813.32 | PE125.7x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$742.00 | -7.9% | 46.4% | NT$19.2t | NT$912.98 | PE22.5x | E16.1% | 1.9% | Semiconductors | ||
AVGO | US$1,224.46 | -7.9% | 96.9% | US$567.4b | US$1,500.96 | PE49x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.875.30 | -0.4% | 51.8% | kr.3.9t | kr.904.20 | PE46.7x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$189.41 | 4.8% | 37.6% | US$544.0b | US$205.53 | PB1.8x | E-1.7% | 2.4% | Banks | ||
WMT | US$60.14 | 0.5% | 19.0% | US$484.6b | US$65.08 | PE31.2x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$120.56 | 1.6% | 3.5% | US$477.2b | US$129.77 | PE13.3x | E-0.6% | 3.2% | Energy | ||
UNH | US$491.23 | 4.8% | -0.1% | US$452.9b | US$568.86 | PE29.5x | E19.7% | 1.5% | Healthcare | ||
700 | HK$320.40 | 5.3% | -7.1% | HK$3.0t | HK$418.08 | PE23.9x | E15.0% | 1.1% | Media | ||
PG | US$160.54 | 2.9% | 2.7% | US$378.9b | US$169.68 | PE25.5x | E6.8% | 2.3% | Household | ||
A005930 | ₩76,100.00 | -7.4% | 16.7% | ₩506.9t | ₩101,991.89 | PE35.7x | E27.4% | 1.9% | Tech | ||
JNJ | US$149.12 | 3.2% | -9.7% | US$359.3b | US$173.60 | PE18.7x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$336.11 | 0.4% | 13.4% | US$333.1b | US$384.83 | PE22x | E4.2% | 2.7% | Retail | ||
MRK | US$126.94 | 1.5% | 8.9% | US$321.5b | US$137.58 | PE880.9x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$715.46 | -0.07% | 42.2% | US$317.3b | US$773.83 | PE46.7x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$114.53 | -5.0% | 21.8% | US$314.8b | US$137.02 | PE29.6x | E14.7% | 1.4% | Software | ||
CVX | US$161.92 | 3.6% | -4.2% | US$299.1b | US$181.53 | PE14x | E2.3% | 4.0% | Energy | ||
ABBV | US$167.89 | 3.3% | 1.8% | US$297.3b | US$184.14 | PE61.7x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
BAC | US$37.73 | 8.8% | 30.8% | US$296.8b | US$39.52 | PB1.1x | E6.2% | 2.5% | Banks | ||
600519 | CN¥1,675.06 | 0.1% | -1.8% | CN¥2.1t | CN¥2,154.31 | PE28.2x | E12.8% | 3.0% | Food, Beverage & Tobacco |